Instrument Inactif

Communiqués ACCM SCIE OTC Markets

Actions

ACMSY

US00442Y1010

Equipement, fournitures et distribution médicale

Communiqués

08/01	AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)	AQ
17/09/25	AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning	AQ
16/09/25	AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th	AQ
17/06/25	AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	AQ
13/06/25	AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	AQ
28/04/25	AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening	AQ
21/04/25	AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	AQ
16/04/25	AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan	AQ
10/04/25	AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	AQ
08/04/25	AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	AQ
04/04/25	AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States	AQ
18/03/25	AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test	AQ
03/01/25	AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	AQ
17/07/23	AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership	AQ
11/07/23	AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer	AQ
09/06/23	ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)	AQ
06/06/23	AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	AQ
31/05/23	AccuStem Announce Strategic Clinical and Operational Partnership	AQ
05/05/23	ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
02/05/23	AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer	AQ
15/02/23	ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
06/12/22	AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	AQ
22/11/22	AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	AQ
16/11/22	ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
16/11/22	AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors	AQ